PROBODY
Live / Registered — Registered — Section 8 accepted (as of 24 Jan 2024)
What this means for you
Registered since 12 Dec 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86983300
- Registration number
- 5355828
- Mark type
- Stylized text
- Filed
- 31 Jul 2015
- Published for opposition
- 23 Feb 2016
- Registered
- 12 Dec 2017
- Attorney of record
- GABRIELLE S. ROTH
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic [ and diagnostic ] agents and preparations consisting primarily of biochemicals, immunoglobulin and antigen-binding fragments for use in cancer therapies; therapeutic [ and diagnostic ] agents, preparations and substances for medical purposes; immunotherapies and therapeutic [ and diagnostic ] agents, preparations and substances in the field of dysregulated proteolytic activity for medical purposes; immunotherapies and therapeutic [ and diagnostic ] agents, preparations and substances in the field of oncology for medical purposes
Owner
- CytomX Therapeutics, Inc., South San Francisco, CA, US
- CytomX Therapeutics, Inc., South San Francisco, CA, US
- CytomX Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 24 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 24 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 24 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Nov 2023 — TEAS SECTION 8 RECEIVED
- 12 Dec 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Jan 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jan 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jan 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Oct 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Oct 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Dec 2017 — REGISTERED-PRINCIPAL REGISTER
- 04 Nov 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Nov 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Nov 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED